Insights from 2023 ESMO Asia Annual Meeting


 

Final Analysis of a Ph2 Study of Neoadjuvant S-1 + Oxaliplatin in Older Patients With Locally Advanced Gastric Cancer

0 views
February 22, 2024
Comments 0
Login to view comments. Click here to Login